Lok Sabha Question No. 3773 (UNSTARRED), answered on 2023-08-11
Subject: Bureau of Pharma PSUs of India
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Sanjay Haribhau Jadhav, Arvind Ganpat Sawant, Sanghamitra Maurya, Keshari Devi Patel

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 3773 TO BE ANSWERED ON THE 11 th  August, 2023

## Bureau of Pharma PSUs of India

†3773. SHRI SANJAY JADHAV: SHRI ARVIND GANPAT SAWANT: DR. SANGHMITRA MAURYA: SHRIMATI KESHARI DEVI PATEL:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) whether the Government has conducted any study/analysis and review of the current status of the implementation of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and if so, the details and the current status thereof, State/UT, district/ block-wise;
- (b) the current status of Bureau of Pharma PSUs of India along with the number of experts of pharmaceutical field working therein at present;
- (c)  whether  the  Government  proposes  to  nominate  renowned  medical  administrators  or Industry expert representatives therein and if so, the details thereof along with the number of representatives who are likely to be nominated; and
- (d)  whether  the  Government  proposes  to  provide  grant  to  BPPI  to  meet  the  administrative expenses, salary etc. on account of it not having financial autonomy and if so, the details thereof and if not, the reasons therefor?

## ANSWER

## MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI BHAGWANTH KHUBA)

(a):  An  evaluation  study  for  'Improving  effectiveness  of Janaushadhi Stores'  was  got conducted  by  the  Department  of  Pharmaceuticals  during  January,  2019.  Considering  the various  suggestions  made  in  the  study  report,  the  Scheme  was  approved  for  further continuation. An analysis of implementation of the scheme based on availability of PMBJKs vis a vis density of the population has subsequently been conducted wherein 651 districts of the  country  were  found  having  deficient  number  of  Kendras.  Based  thereon,  online applications  have  been  invited  from  these  districts.  Till  31.07.2023,  about  9,668 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) have been opened all across the country.

- (b) & (c): Pharmaceuticals & Medical Devices Bureau of India (PMBI) [previously Bureau of Pharma PSUs of India (BPPI)], the implementing agency of the scheme is a society registered under the Societies Registration Act, 1860. The Bureau is headed by Chief Executive Officer (CEO).  Governing  Council,  under  the  chairmanship  of  the  Secretary,  Department  of Pharmaceuticals has CMD/ MDs of the Pharma PSUs as members, as industry representatives. Further,  a  committee  has  been  constituted  to  review  the  product  basket,  having  academic,

medical  and  regulatory  experts  from  National  Institute  of  Pharmaceutical  Education  & Research (NIPER), Directorate General of Health Services (DGHS), Central Drugs Standard Control  Organization  (CDSCO)  and  National  Pharmaceutical  Pricing  Authority  (NPPA) respectively.

(d):  Government  releases  grants  to  PMBI  for  providing  incentives  to Kendra owners, procurement of products to be sold at discounted rates, media & publicity and establishment expenses of Pharma Bureau set up under PMBI.

*****